Adult

Infective Endocarditis Treatment

Warning

Empirical antibiotic treatment - pending blood culture results - before pathogen identification (typically for less than 48hours)

  • Micro/ID should be consulted in all cases of possible endocarditis
  • Cardiology should be consulted in all cases of confirmed endocarditis and those where there is a high clinical suspicion pending further investigation.
  • Ideally DO NOT start antibiotics until after discussion with Micro/ID.
  • Ideally, take a minimum of 3 blood culture sets (6 bottles, 8-10ml per bottle) before antibiotic administration; if possible have a gap of at least 30min between sets.
  • Antibiotic therapy should be refined based on blood culture results. 
  • True culture negative endocarditis is rare – Micro/ID will advise on-going treatment and investigation in such cases.
  • Ensure penicillin allergy is properly investigated. Consider penicillin allergy assessment and delabelling
  • Patients requiring aminoglycosides for 2 weeks or more for infective endocarditis: See Audiometry and intravenous aminoglycosides guidance. 

Criteria for diagnosis of Endocarditis

Criteria used are from ESC 2015 modified criteria and 2023 update, table 56

Definite IE:

·         Pathological criteria:

  • o   Microorganisms demonstrated by culture or on histological examination of a vegetation, a vegetation that has embolised, or an intracardiac abscess specimen;
  • o   or Pathological lesions; vegetation or intracardiac abscess by histological examination showing active endocarditis

·         Clinical criteria:  

  • o   2 major criteria;
  • o   or 1 major criterion and 3 minor criteria;
  • o   or 5 minor criteria

Major criteria:

  1. Blood cultures positive for S. aureus
  2. Imaging positive for IE:
  1. Echo-cardiogram positive for IE: including vegetation, abscess, pseudo-aneurysm, intra-cardiac fistula, valvular perforation or aneurysm, or new partial dehisence of prosthetic valve.
  2. Abnormal activity around the site of prosthetic valve implantation detected by 18F-FDG PET/CT (only if the prosthesis was implanted for >3 months) or radiolabelled leukocytes SPECT/CT
  3. Definite para-valvular lesions by cardiac CT

Minor criteria:

  1. Predisposition such as predisposing heart condition, or injection drug use.
  2. Fever defined as temperature >38°C.
  3. Vascular phenomena (including those detected by imaging only): Major arterial emboli, septic pulmonary infarcts, infectious (mycotic) aneurysm, intracranial haemorrhage, conjunctival haemorrhages, and Janeway’s lesions.
  4. Immunological phenomena: glomerulonephritis, Osler’s nodes, Roth’s spots, and rheumatoid factor.
  5. Microbiological evidence: positive blood culture but does not meet a major criterion as noted above

Community acquired native valve OR late (more than 12 months post-surgery) prosthetic valve endocarditis

Preferred:

amoxicillin 2g iv every 4 hours                                     

AND flucloxacillin 2g iv every 4 hours

AND gentamicin 3mg/kg iv od. For levels and dose adjustment see gentamicin Infective endocarditis monitoring guideline

 

For penicillin allergy (non-severe)

cefazolin* 2g tds iv

AND gentamicin 3mg/kg iv od. For levels and dose adjustment see gentamicin Infective endocarditis monitoring guideline

*Caution: Prothrombin time, INR and APTT may increase on cefazolin treatment courses, please monitor. For more information see Cefazolin associated coagulation disorders

 

For penicillin allergy (severe) OR MRSA positive patients

vancomycin iv see monograph for dosing 

AND gentamicin 3mg/kg iv od. For levels and dose adjustment see gentamicin Infective endocarditis monitoring guideline

Nosocomial/healthcare associated or early prosthetic valve (less than 12 months post-surgery) endocarditis

Including implantable cardiac electronic device-associated endocarditis

Preferred (including penicillin allergy (severe and non-severe) and MRSA positive patients

vancomycin iv see monograph for dosing

AND gentamicin 3 mg/kg iv od. For levels and dose adjustment see gentamicin Infective endocarditis monitoring guideline 

(rifampicin may be recommended by Micro/ID after 3-5 days)

Editorial Information

Last reviewed: 01 Nov 2024

Next review date: 01 Nov 2027

Author(s): AMST.